TY - JOUR AU - Joensuu, H. AU - Kellokumpu-Lehtinen, P. -. L. AU - Bono, P. AU - Alanko, T. AU - Kataja, V. AU - Asola, R. PY - 2006 DA - 2006// TI - Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer JO - N Engl J Med. VL - 354 UR - https://doi.org/10.1056/NEJMoa053028 DO - 10.1056/NEJMoa053028 ID - Joensuu2006 ER - TY - JOUR AU - Slamon, D. AU - Eiermann, W. AU - Robert, N. AU - Pienkowski, T. AU - Martin, M. AU - Press, M. PY - 2011 DA - 2011// TI - Adjuvant trastuzumab in HER2-positive breast cancer JO - N Engl J Med. VL - 365 UR - https://doi.org/10.1056/NEJMoa0910383 DO - 10.1056/NEJMoa0910383 ID - Slamon2011 ER - TY - JOUR AU - Piccart-Gebhart, M. J. AU - Procter, M. AU - Leyland-Jones, B. AU - Goldhirsch, A. AU - Untch, M. AU - Smith, I. PY - 2005 DA - 2005// TI - Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer JO - N Engl J Med. VL - 353 UR - https://doi.org/10.1056/NEJMoa052306 DO - 10.1056/NEJMoa052306 ID - Piccart-Gebhart2005 ER - TY - JOUR AU - Hudis, C. A. PY - 2007 DA - 2007// TI - Trastuzumab – Mechanism of action and use in clinical practice JO - N Engl J Med. VL - 357 UR - https://doi.org/10.1056/NEJMra043186 DO - 10.1056/NEJMra043186 ID - Hudis2007 ER - TY - JOUR AU - Nahta, R. AU - Esteva, F. J. PY - 2007 DA - 2007// TI - Trastuzumab: triumphs and tribulations JO - Oncogene. VL - 26 UR - https://doi.org/10.1038/sj.onc.1210379 DO - 10.1038/sj.onc.1210379 ID - Nahta2007 ER - TY - JOUR AU - Levy, D. E. AU - Lee, C. PY - 2002 DA - 2002// TI - What does Stat3 do? JO - J Clin Invest. VL - 109 UR - https://doi.org/10.1172/JCI0215650 DO - 10.1172/JCI0215650 ID - Levy2002 ER - TY - JOUR AU - Sinibaldi, D. AU - Wharton, W. AU - Turkson, J. AU - Bowman, T. AU - Pledger, W. J. AU - Jove, R. PY - 2000 DA - 2000// TI - Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling JO - Oncogene. VL - 19 UR - https://doi.org/10.1038/sj.onc.1203947 DO - 10.1038/sj.onc.1203947 ID - Sinibaldi2000 ER - TY - JOUR AU - Bowman, T. AU - Broome, M. A. AU - Sinibaldi, D. AU - Wharton, W. AU - Pledger, W. J. AU - Sedivy, J. M. PY - 2001 DA - 2001// TI - Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis JO - Proc Natl Acad Sci U S A. VL - 98 UR - https://doi.org/10.1073/pnas.131568898 DO - 10.1073/pnas.131568898 ID - Bowman2001 ER - TY - JOUR AU - Niu, G. AU - Wright, K. L. AU - Huang, M. AU - Song, L. AU - Haura, E. AU - Turkson, J. PY - 2002 DA - 2002// TI - Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis JO - Oncogene. VL - 21 UR - https://doi.org/10.1038/sj.onc.1205260 DO - 10.1038/sj.onc.1205260 ID - Niu2002 ER - TY - JOUR AU - Chang, Q. AU - Bournazou, E. AU - Sansone, P. AU - Berishaj, M. AU - Gao, S. P. AU - Daly, L. PY - 2013 DA - 2013// TI - The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis JO - Neoplasia New York N. VL - 15 UR - https://doi.org/10.1593/neo.13706 DO - 10.1593/neo.13706 ID - Chang2013 ER - TY - JOUR AU - Azare, J. AU - Doane, A. AU - Leslie, K. AU - Chang, Q. AU - Berishaj, M. AU - Nnoli, J. PY - 2011 DA - 2011// TI - Stat3 mediates expression of autotaxin in breast cancer JO - PLoS One. VL - 6 UR - https://doi.org/10.1371/journal.pone.0027851 DO - 10.1371/journal.pone.0027851 ID - Azare2011 ER - TY - JOUR AU - Sonnenblick, A. AU - Shriki, A. AU - Galun, E. AU - Axelrod, J. H. AU - Daum, H. AU - Rottenberg, Y. PY - 2012 DA - 2012// TI - Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis JO - Clin Transl Oncol. VL - 14 UR - https://doi.org/10.1007/s12094-012-0789-z DO - 10.1007/s12094-012-0789-z ID - Sonnenblick2012 ER - TY - JOUR AU - Sonnenblick, A. AU - Uziely, B. AU - Nechushtan, H. AU - Kadouri, L. AU - Galun, E. AU - Axelrod, J. H. PY - 2013 DA - 2013// TI - Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer JO - Breast Cancer Res Treat. VL - 138 UR - https://doi.org/10.1007/s10549-013-2453-x DO - 10.1007/s10549-013-2453-x ID - Sonnenblick2013 ER - TY - JOUR AU - Yu, H. AU - Pardoll, D. AU - Jove, R. PY - 2009 DA - 2009// TI - STATs in cancer inflammation and immunity: a leading role for STAT3 JO - Nat Rev Cancer. VL - 9 UR - https://doi.org/10.1038/nrc2734 DO - 10.1038/nrc2734 ID - Yu2009 ER - TY - STD TI - Responsify. www.responsify-fp7.eu UR - http://www.responsify-fp7.eu ID - ref15 ER - TY - STD TI - Gene Expression Omnibus. Gene profiling of HER2 breast cancer patients treated with adjuvant trastuzumab. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ulwbuuwgpzqphsh&acc=GSE58984. UR - http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ulwbuuwgpzqphsh&acc=GSE58984 ID - ref16 ER - TY - STD TI - Gene Expression Omnibus. FinHER trial: Patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=wfermmkijzktzcb&acc=GSE65095. UR - http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=wfermmkijzktzcb&acc=GSE65095 ID - ref17 ER - TY - STD TI - cBioPortal for Cancer Genomics. www.cbioportal.org/public-portal/index.do. UR - http://www.cbioportal.org/public-portal/index.do ID - ref18 ER - TY - JOUR AU - Network, C. G. A. PY - 2012 DA - 2012// TI - Comprehensive molecular portraits of human breast tumours JO - Nature. VL - 490 UR - https://doi.org/10.1038/nature11453 DO - 10.1038/nature11453 ID - Network2012 ER - TY - JOUR AU - Subramanian, A. AU - Tamayo, P. AU - Mootha, V. K. AU - Mukherjee, S. AU - Ebert, B. L. AU - Gillette, M. A. PY - 2005 DA - 2005// TI - Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles JO - Proc Natl Acad Sci. VL - 102 UR - https://doi.org/10.1073/pnas.0506580102 DO - 10.1073/pnas.0506580102 ID - Subramanian2005 ER - TY - JOUR AU - Korkaya, H. AU - Kim, G. AU - Davis, A. AU - Malik, F. AU - Henry, N. L. AU - Ithimakin, S. PY - 2012 DA - 2012// TI - Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population JO - Mol Cell. VL - 47 UR - https://doi.org/10.1016/j.molcel.2012.06.014 DO - 10.1016/j.molcel.2012.06.014 ID - Korkaya2012 ER - TY - JOUR AU - Saal, L. H. AU - Johansson, P. AU - Holm, K. AU - Gruvberger-Saal, S. K. AU - She, Q. -. B. AU - Maurer, M. PY - 2007 DA - 2007// TI - Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity JO - Proc Natl Acad Sci U S A. VL - 104 UR - https://doi.org/10.1073/pnas.0702507104 DO - 10.1073/pnas.0702507104 ID - Saal2007 ER - TY - JOUR AU - Ignatiadis, M. AU - Singhal, S. K. AU - Desmedt, C. AU - Haibe-Kains, B. AU - Criscitiello, C. AU - Andre, F. PY - 2012 DA - 2012// TI - Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis JO - J Clin Oncol. VL - 30 UR - https://doi.org/10.1200/JCO.2011.39.5624 DO - 10.1200/JCO.2011.39.5624 ID - Ignatiadis2012 ER - TY - JOUR AU - Farmer, P. AU - Bonnefoi, H. AU - Anderle, P. AU - Cameron, D. AU - Wirapati, P. AU - Becette, V. PY - 2009 DA - 2009// TI - A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer JO - Nat Med. VL - 15 UR - https://doi.org/10.1038/nm.1908 DO - 10.1038/nm.1908 ID - Farmer2009 ER - TY - JOUR AU - Desmedt, C. AU - Majjaj, S. AU - Kheddoumi, N. AU - Singhal, S. K. AU - Haibe-Kains, B. AU - Ouriaghli, F. PY - 2012 DA - 2012// TI - Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-0383 DO - 10.1158/1078-0432.CCR-11-0383 ID - Desmedt2012 ER - TY - JOUR AU - Yoshihara, K. AU - Shahmoradgoli, M. AU - Martínez, E. AU - Vegesna, R. AU - Kim, H. AU - Torres-Garcia, W. PY - 2013 DA - 2013// TI - Inferring tumour purity and stromal and immune cell admixture from expression data JO - Nat Commun. VL - 4 UR - https://doi.org/10.1038/ncomms3612 DO - 10.1038/ncomms3612 ID - Yoshihara2013 ER - TY - JOUR AU - Finak, G. AU - Bertos, N. AU - Pepin, F. AU - Sadekova, S. AU - Souleimanova, M. AU - Zhao, H. PY - 2008 DA - 2008// TI - Stromal gene expression predicts clinical outcome in breast cancer JO - Nat Med. VL - 14 UR - https://doi.org/10.1038/nm1764 DO - 10.1038/nm1764 ID - Finak2008 ER - TY - JOUR AU - Osmanbeyoglu, H. U. AU - Pelossof, R. AU - Bromberg, J. F. AU - Leslie, C. S. PY - 2014 DA - 2014// TI - Linking signaling pathways to transcriptional programs in breast cancer JO - Genome Res. VL - 24 UR - https://doi.org/10.1101/gr.173039.114 DO - 10.1101/gr.173039.114 ID - Osmanbeyoglu2014 ER - TY - JOUR AU - Tell, R. W. AU - Horvath, C. M. PY - 2014 DA - 2014// TI - Bioinformatic analysis reveals a pattern of STAT3-associated gene expression specific to basal-like breast cancers in human tumors JO - Proc Natl Acad Sci U S A. VL - 111 UR - https://doi.org/10.1073/pnas.1404881111 DO - 10.1073/pnas.1404881111 ID - Tell2014 ER - TY - JOUR AU - Li, G. AU - Zhao, L. AU - Li, W. AU - Fan, K. AU - Qian, W. AU - Hou, S. PY - 2014 DA - 2014// TI - Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression JO - Oncotarget. VL - 5 UR - https://doi.org/10.18632/oncotarget.2135 DO - 10.18632/oncotarget.2135 ID - Li2014 ER - TY - JOUR AU - Chung, S. S. AU - Giehl, N. AU - Wu, Y. AU - Vadgama, J. V. PY - 2014 DA - 2014// TI - STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits JO - Int J Oncol. VL - 44 ID - Chung2014 ER - TY - JOUR AU - Dolled-Filhart, M. AU - Camp, R. L. AU - Kowalski, D. P. AU - Smith, B. L. AU - Rimm, D. L. PY - 2003 DA - 2003// TI - Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis JO - Clin Cancer Res VL - 9 ID - Dolled-Filhart2003 ER - TY - JOUR AU - Sansone, P. AU - Bromberg, J. PY - 2012 DA - 2012// TI - Targeting the Interleukin-6/Jak/Stat pathway in human malignancies JO - J Clin Oncol. VL - 30 UR - https://doi.org/10.1200/JCO.2010.31.8907 DO - 10.1200/JCO.2010.31.8907 ID - Sansone2012 ER -